Document is current
Any future updates will be listed below
-
Authors
,
Jyväkorpi, S. K. https://orcid.org/0000-0001-5901-3584
Ramel, A.
Strandberg, T. E.
Piotrowicz, K.
Błaszczyk-Bębenek, E.
Urtamo, A.
Rempe, H. M.
Geirsdóttir, Ó.
Vágnerová, T.
Billot, M.
Larreur, A.
Savera, G.
Soriano, G.
Picauron, C.
Tagliaferri, S.
Sanchez-Puelles, C.
Cadenas, V. Sánchez
Perl, A.
Tirrel, L.
Öhman, H.
Weling-Scheepers, C.
Ambrosi, S.
Costantini, A.
Pavelková, K.
Klimkova, M.
Freiberger, E.
Jonsson, P. V.
Marzetti, E.
Pitkälä, K. H.
Landi, F.
Calvani, R.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (IMI-JU 115621)
Juho Vainion Säätiö
University of Helsinki including Helsinki University Central Hospital
- License Information
-
More Information
Article History
Received: 12 October 2020
Accepted: 9 December 2020
First Online: 13 February 2021
Compliance with ethical standards
:
: All the authors have worked for the SPRINTT project, an Innovative Medicines Initiative -funded project which included partners from the European Federation of Pharmaceutical Industries and Associations (EFPIA).
: Ethical approval SPRINTT was approved by national ethics committees.
: All participants provided a written informed consent prior to enrolment.
